Cancer death rates set to drop 17 per cent by 2030

September 25, 2012

(Medical Xpress)—The rates of people dying from cancer are predicted to fall by 17 per cent (16.8) in the UK by 2030 according to new statistics released today by Cancer Research UK.

For all cancers, adjusting for age, 170 people in every 100,000 died from the disease in 2010 but by 2030 it is predicted this will fall to 142 in every 100,000.  This is largely due to better , thanks to earlier diagnosis and improved treatments, but also reflects a reduction in smoking-related cancers leading to fewer deaths.

The new figures are released in the run-up to Stand Up To Cancer - an unprecedented partnership between Cancer Research UK and Channel 4 - which will culminate in a television fundraising entertainment extravaganza live on TV on Friday October 19th.

will see the biggest fall in people dying, with death rates expected to reduce by over 40 per cent (42.6) – dropping from 9.1 women per 100,000 to 5.3 by 2030.

The figures also show that in women, bowel and will have huge reductions in the number of people in every 100,000 dying – falling by 28 per cent for female breast cancer, 23 per cent for and 16 per cent for prostate cancer.  

But there are some cancers where the death rates are set to increase – 22 per cent for from 2.9 to 3.5 per 100,000 people and 39 per cent for , from 4.2 to 5.9 per 100,000.  

Professor Peter Sasieni, Cancer Research UK at Queen Mary, University of London, said: "Our latest estimations show that for many cancers, adjusting for age, are set to fall dramatically in the coming decades. And what's really encouraging is that the biggest cancer killers – lung, breast, bowel, and prostate – are part of this falling trend.

"Because old age is the biggest risk factor for cancer and more people are living longer, they have a greater chance of developing and, unfortunately, dying from the disease. But, overall, the proportion - or rate - of those who die from cancer is falling."

Dr Harpal Kumar, Cancer Research UK's chief executive, said: "These new figures are encouraging and highlight the huge progress we're making. Research across many areas is having real impact.

"But we know there's still so much more to do if we are to reach a day when no-one dies prematurely from cancer. We continue to rely on the public's generosity to drive progress. This helps us turn discoveries made in our science labs into new treatments and to carry out clinical trials to find the best ways to treat patients.

"There are more exciting opportunities now to make a step-change than at any other time in history and we must grasp these. But to do so will require more investment and that's why we're asking people to help us through Stand Up To Cancer. It's about working together to improve the odds of surviving cancer.  We want to bring forward the day when no-one loses their life prematurely to this devastating disease."

Explore further: Cancer is the biggest premature killer

More information: Data provided on request by the Wolfson Institute based on methodology set out in Mistry M, Parkin D, Ahmad A, Sasieni P. Cancer incidence in the UK: Projections to the year 2030 British Journal of Cancer Vol 105 page 1795–1803.

Related Stories

Cancer is the biggest premature killer

November 3, 2011
Cancer is responsible for killing 40 per cent of all the men and women who die prematurely between the ages of 25 and 74 in the UK – according to a new analysis of the figures released today by Cancer Research UK.

People fear cancer more than other serious illness

August 16, 2011
More than a third of people in the UK fear cancer more than other life-threatening conditions – such as Alzheimer’s, stroke and heart disease according to a Cancer Research UK survey.

Bowel cancer risk doubles for men

July 27, 2011
Men’s chances of getting bowel cancer in Great Britain have doubled since the mid 70s - according to new figures released today by Cancer Research UK.

Screening helps early diagnosis of bowel cancer

June 18, 2012
(Medical Xpress) -- Patients who attend bowel screening are more likely to be diagnosed with bowel cancer at an early stage - when there is a better chance of survival - than those who wait until they have symptoms of the ...

Latest cancer research unveiled

June 20, 2011
Two leading experts from the Division of Cancer Studies at King’s presented their latest research into cancer survival this week at the National Cancer Intelligence Network conference in London.

Womb cancer deaths rise by a fifth in the last decade

April 5, 2012
(Medical Xpress) -- Deaths from womb (uterine) cancer have risen by nearly twenty per cent in the last decade, according to new figures from Cancer Research UK today.

Recommended for you

A metabolic treatment for pancreatic cancer?

August 15, 2017
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent. Research ...

Skewing the aim of targeted cancer therapies

August 15, 2017
Headlines, of late, have touted the successes of targeted gene-based cancer therapies, such as immunotherapies, but, unfortunately, also their failures.

Findings pave way for three-drug combination treatment for childhood leukemia

August 15, 2017
UCLA researchers have developed a new approach that could eventually help young people respond better to treatment for acute lymphoblastic leukemia. The scientists discovered in mice that when the production of nucleotides—also ...

Does stronger initial response to cancer treatment predict longer overall survival?

August 15, 2017
It seems like such a simple question: Do patients whose tumors shrink more in response to targeted treatment go on to have better outcomes than patients whose tumors shrink less? Actually, the answer seems simple too. In ...

New study reveals late spread of breast cancer and backs key role of early diagnosis

August 14, 2017
Breast cancer cells that spread to other parts of the body break off and leave the primary tumour at late stages of disease development, scientists from the Wellcome Trust Sanger Institute and their collaborators have found.

Discovery of new prostate cancer biomarkers could improve precision therapy

August 14, 2017
Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine. In the publication, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.